Security Stocks; TransTech Systems, a Subsidiary of Visualant (OTCBB:VSUL), to Exhibit at the International Security Conference & Exposition

SEATTLE - March 31, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading color based identification and diagnostic solutions, an emerging leader in security and authentication systems technology and distributor of a wide variety of security solutions through its wholly-owned subsidiary, TransTech Systems, Inc., is pleased to announce that TransTech Systems will be exhibiting at the International Security Conference & Exposition from April 6-8, 2011 at the Sands Expo & Convention Center in Las Vegas, NV.

The International Security Conference & Exposition (ISC West) is one of the fastest growing tradeshows in North America according to the publication Tradeshow Week. With over 23,000 industry professionals and 14,600 security buyers, ISC West is certainly the nation's largest security event of the year. ISC West will be hosting education sessions from April 5-7, 2011 as well as the exposition from April 6-8, 2011. See www.iscwest.com for more information.
TransTech Systems (www.ttsys.com) will be exhibiting the latest in identification card printing and encoding systems and building access control products from manufacturers such as Evolis, NiSCA, FarPointe, and Datacard. TransTech also will be demonstrating the new Visualant Spectral Pattern Matching technology. See these and other popular security industry products on display in TransTech's booth #22129.
We will post this press release on the Visualant website at www.visualant.net. If we have an email address for you, we will send you a copy of our press releases electronically. We want to remind you that if you have not already done so, please enter your email and other information on the form on the website at: http://visualant.net/contactus.html.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com

Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs. (2500 per month)

Wind Stock Trading Alert; Clean Wind Energy Tower, Inc. (OTCBB: CWET) Trading up 13.64%

Point Roberts, WA - March 30, 2011 - Investorideas.com, a leader in cleantech stock research, releases a trading alert for wind stock, Clean Wind Energy Tower, Inc (OTCBB: CWET). The stock is trading at $0.25, up $ 0.03 (13.64%) in morning trading.
The Company recently announced it filed with the United States Patent & Trademark Office "A Petition to Make Special under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
News:http://www.investorideas.com/CO/CWE/news/2011/03071.asp
Clean Wind Energy Tower, Inc (OTCBB:CWET) www.cleanwindenergytower.com
Clean Wind Energy, Inc. a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large “Downdraft Towers” that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity.

p>Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. Visit the showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Contact the company:
410-972-4713
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on Clean Wind Energy,
http://www.investorideas.com/Resources/Newsletter.asp
Research more wind stocks with the renewable energy stocks directory
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 shares 144) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information about Investorideas.com green stocks contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com

Biotech/Pharma Stock News; BioSante Pharmaceuticals (NASDAQ: BPAX) Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials

LINCOLNSHIRE, Ill. - March 30, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that enrollment of subjects in the second of two pivotal Phase III LibiGel (testosterone gel) safety and efficacy trials has been completed. Enrollment in the first LibiGel efficacy trial was completed in February. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.

"This is an important achievement for BioSante and a key step toward completing the LibiGel Phase III clinical development program," said Joanne Zborowski, BioSante's vice president of clinical development. "There are more than 1,000 subjects in the efficacy trials and we anticipate announcing top-line efficacy data this fall. In addition, we have over 3,000 subjects enrolled in our LibiGel Phase III safety study," she added.
Phillip B. Donenberg, BioSante's senior vice president of finance & CFO commented, "This key LibiGel achievement, coupled with our successful financing strategy, guarantees a solid timeline for Phase III efficacy data, with sufficient funds to finance our operations and LibiGel clinical development through that data and well into 2012. As a result, we have removed near-term financial risk from BioSante without the need for additional funds."
About LibiGel®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD). Enrollment has been completed in the two on-going Phase III efficacy trials which are double-blind, placebo-controlled trials of approximately 500 surgically menopausal women each. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the United States, in surgically menopausal women distressed by their low sexual desire and activity.
BioSante also is conducting a Phase III LibiGel safety study, a randomized, double-blind, placebo-controlled, multi-center, cardiovascular (CV) events and breast cancer study that has enrolled over 3,000 women. The study will continue for a total of five years, however, BioSante can use the safety study data as part of an NDA submission after an average of 12 months of exposure to LibiGel or placebo.
The LibiGel safety study is tracking a predefined list of CV events, in agreement with the FDA, including CV death, myocardial infarction and stroke in women 50 years of age or older and suffering from at least two CV risk factors including hypertension and diabetes. The objective of the safety study is to show the relative safety of testosterone compared to placebo in the number of CV events. The incidence of breast cancer also is being tracked over the course of the study.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Woodford Shale Emerging as a Leading Domestic Oil and Gas Play

Point Roberts WA - March 30, 2011 - www.Investorideas.com, an investor research portal specialized in sector research including oil and gas stocks, releases the following CFA commentary on the Woodford Shale play from Patrick J. Murphy, featuring American Petro-Hunter, Inc. (OTC.BB:AAPH).

Patrick J. Murphy is the owner of Murphy Analytics LLC, a provider of sponsored research coverage on smallcap stocks.
Woodford Shale Emerging as a Leading Domestic Oil and Gas Play
As noted by American Petro-Hunter (OTCBB:AAPH) CEO Robert McIntosh in the Company's January 2011 Corporate Newsletter, production in the Woodford Shale has skyrocketed over the last few years. CEO McIntosh and others have referred to the Woodford as a world class oil and gas target, an assertion that seems justified given that the Woodford Shale now ranks second domestically in gas production and fifth in oil production. Following is data and commentary related to the operations and outlook for some of the Woodford Shale's most active players.
Devon Energy (NYSE: DVN): In a presentation at the Oppenheimer Unconventional Oil and Gas Conference, DVN noted that its Woodford assets benefit from a low cost of entry at approximately $2,200 per acre and a low average royalty burden at approximately 21%. The Company also notes that it recently completed construction of a gas processing plant, and after drilling 87 wells in 2010, DVN plans to drill over 200 wells in the Cana-Woodford Shale in 2011. Discussing the Company's Q4 2010 earnings, CFO and Executive Vice President Jeffrey Agosta commented on DVN's interest in the shale:
"Moving to the Cana-Woodford Shale in Western Oklahoma, we continue to add to our acreage position during the fourth quarter and now have approximately 243,000 net acres. Devon is currently operating 23 out of the 39 rigs running play-wide."
Marathon Oil (NYSE: MRO): At a recent Credit Suisse conference, MRO noted its interest in the Anadarko Woodford Shale play, with 3 rigs operating currently and 8 planned by the end of 2011. The company also observed that returns there are among the highest of domestic resource plays, and while exiting 2010 at approximately 1,500 BOED, MRO estimates that, by 2015, it could reach a peak rate of 30,000 BOED. In the Company's Q4 2010 conference call, Executive Vice President David Roberts noted that MRO plans to more than double its acreage in the area:
"Marathon also holds 86,000 acres in the Anadarko Woodford area, an area where we have operated for decades, and we have line in sight on new opportunity to increase that position to over 100,000 acres shortly. Importantly, we will have eight rigs in the play by 2011 by the end of this year."
Continental Resources (NYSE: CLR): In its October 2010 Investor Day Presentation, CLR noted that the Company is the top leaseholder in Anadarko Woodford, with 252,000 net lease acres. The Company also notes that its first Woodford well was completed in Q1 08, and had increased to over 25 by July of 2010. For 2011, 20% of CLR's $1.4 billion capex budget will be spent in Woodford, which it refers to as one of the plays critical for tripling the Company's production from 2010 to 2014. Commenting on CLR's view of the Woodford during the Q4 earnings call, President and COO Jeffrey Hume said:
"We're very encouraged with what we are seeing in Anadarko Woodford. In early 2010, we stepped out into the Northwest in the Anadarko Woodford in Blaine and Dewey Counties and demonstrated that the Anadarko Woodford was much larger and had more potential than just the core Canadian County part of the play. We were successful and other operators have followed. Activity has ramped up dramatically in the Northwest Cana where there are now 43 rigs drilling."
Cimarex Energy (NYSE: XEC): Noted in the Credit Suisse presentation, XEC has over 100,000 net acres leased in the western Oklahoma Cana-Woodford play, and with eight operating rigs, this is the Company's largest single investment area. In 2010, XEC spent $335 million in capex in Woodford, increasing by 65% over 2009 its net wells drilled in the region, and XEC notes it expects "significant future drilling" in the Woodford. Commenting on the Company's view of the Woodford opportunity in the Q4 earnings call, Executive Vice President of Exploration Thomas Jorden stated:
"There's a lot here we're still trying to figure out, but we are absolutely delighted with this play and what it will contribute to our 2011 and beyond. This is a huge, huge impact to our reserves production and future capital program. We're having very, very good results."
Newfield Exploration (NYSE: NFX): As noted in its presentation for the Simmons & Company International Energy Conference, NFX plans to double or triple the number of wells drilled 2011 in the Woodford Shale, where the Company has 172,000 net acres. NFX also plans to continue to assess additional locations in the western area of its acreage, which the Company considers to be "oily drilling" and in the eastern area of its acreage, which NFX characterizes as more gas prone. In the Company's Q4 2010 earnings call, Chairman, CEO and President Lee Boothby address the Company's growing understanding of the Woodford play as well as the commitment to further investment there:
"Last week, we talked about a new play for us in the area: the Oily Woodford. Over the last two years, we've drilled a half a dozen wells to assess the Woodford on the western side of our Arkoma Basin acreage. We see the potential to drill more than 100 wells in this new play area, a great option to have during a period of low gas prices. For those of you that remember our original Woodford maps or toured the Woodford Shale back in 2006, you may recall a line that ran north to south across our acreage, separating the basin centered gas acreage to the east from the wet gas oil prone acreage to the west. Our tremendous learning curve in drilling efficiency gains and learnings relative to oil shales for the last couple of years have helped us crack the code in this new play area…Because of the oil and rich gas, the economics of this play have pushed it toward the top of our investment list. We plan to drill 12 to 18 wells here in 2011."
New production technology and higher overall energy prices have not only made shale gas reserves an important of our domestic energy policy, but also create an appealing investment opportunity for those interested in the major oil and gas producers as well as the juniors, like American Petro-Hunter. While the majors ramp up production much more quickly than is possible for the juniors, the smaller producers do benefit significantly from the knowledge gained by the majors, and are able to incorporate this information into their drilling activity, enabling juniors like AAPH and others to benefit from the significantly larger capex budgets of the majors, and making them an investment opportunity worth investigating.
Patrick Murphy Bio:
Patrick J. Murphy is the owner of Murphy Analytics LLC, a provider of sponsored research coverage on smallcap stocks. Mr. Murphy has over 15 years of capital markets experience providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's. In addition to his work with Murphy Analytics, Mr. Murphy also serves as a consultant to a municipal derivatives advisory firm. Mr. Murphy is an alumnus of the University of Notre Dame (1991), with an undergraduate degree in Economics, and earned a Masters Degree in Finance from St. Louis University in 1997. Mr. Murphy is a CFA Charterholder and a member of the CFA Society of St. Louis.
Patrick Murphy Disclaimer:
Readers are advised that the above article is solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. The views expressed herein are based upon the author's analysis of the issuer's public disclosures, and assumes both their accuracy and completeness. The opinions and statements included herein are based on sources (including the companies discussed and public sources) believed to be reliable and in good faith, but no representation or warranty, express or implied, is made as to their accuracy, completeness or correctness. The author has not independently verified the information contained herein. This information is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. You should review a complete information package on all companies, which should include, but not be limited to, the Company's annual report, quarterly reports, press releases and all regulatory filings. The foregoing discussion contains statements which are based on current expectations, estimates and projections, and differences from such expectations, estimates and projections can be expected.
The author, Patrick Murphy, was compensated $350 for writing this article by InvestorIdeas.com. Mr. Murphy does not own shares of any of the companies mentioned in this article. Mr. Murphy expects his research firm, Murphy Analytics, to be engaged for the provision of a research report on AAPH in March 2011.
More info: American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the hunt for domestic petroleum assets. www.americanpetrohunter.com
Company Research
http://www.aaphreport.com/
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Contact American Petro-Hunter:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks.
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB) is a showcase energy stock on Investorideas.com and all related energy portals and blogs ( averaging two thousand per month) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Clean Energy Car Stocks Trading Alert; EVCARCO (OTCBB: EVCA) up 45% in Today's Trading

March 29, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leading global investor and industry portal covering the green and renewable energy sector reports on electric car stocks and battery stocks news and trading.
Oil is trading at $104.80 +0.82 +0.79%.
Electric car stock, EVCARCO (OTCBB: EVCA) (www.evcarco.com), is currently trading at $0.0270, up 0.0085 (45.95%).
Company Snapshot
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles

EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles
Market Snapshot

• Dow 12,269.82 +71.94 +0.59%
• Nasdaq 2,749.63 +18.95 +0.69%
• S&P 500 1,316.63 +6.44 +0.49%
• 10 Yr Bond (%) 3.4950% +0.0470
• Oil 104.80 +0.82 +0.79%
• Gold 1,419.80 0.00 0.00%

Research electric car stocks and green auto stocks , lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.
To become a showcase company, contact us below.
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com

"Cleantech is getting more attention again from Wall Street and Independent Investors" - Josh Levine

New York, NY, Point Roberts WA, March 29, 2011 � Investorideas.com, a leader in cleantech investor research features a recent interview with Josh Levine of the MicroCap Investor newsletter, discussing cleantech investment strategies.

Rising oil prices and the recent nuclear disaster in Japan have created renewed interest in the cleantech sector that some analyst think is the real thing and here to stay .In an environment of rising oil prices, Levine sees major investment opportunities in Cleantech.
Josh discusses his recent addition to his portfolio and why and his overall strategy for finding cleantech plays in the microcap markets.
Investorideas.com Interview Excerpt:
Q: Investorideas.com
Josh, with oil prices surging above $100, cleantech is getting a lot more attention again from Wall Street and independent investors. I know you look at the long term investment picture, so what do you think is driving cleantech and what is your outlook for opportunities in this sector?
A: Josh Levine, MicroCap Investor
Let's first qualify what is meant by the term cleantech. Cleantech is often used interchangeably with green technologies and alternative energy, but it seems to be the one that's emerged to encompass all these things. Cleantech essentially covers technologies that are more energy-efficient than conventional technologies and offer more environmentally-friendly alternatives to fossil-fuel-driven energy applications.
Broadly speaking, the world is always moving towards more efficient use of resources. Year after year and decade after decade, we manage to get more out of a given amount of resources. The first industrial revolution was powered by coal and though it provided tremendous gains in production, the pollution negatively impacted the quality of life and health of millions of people.
Q: Investorideas.com
You recently just added a new cleantech stock to your portfolio. Can you give us some insight as to what qualified this particular stock based on your investing model?
A: Josh Levine, MicroCap Investor
My latest recommendation in unusual company which has developed and commercialized environmentally safe alternatives to plastics used for food containers, utensils, product wraps, as well as a wide range of parts in autos and many other things. Importantly, it meets all of my most important criteria for a great microcap investment.
As a cleantech play, this company's biodegradeable and completely safe products can replace petroleum-based polypropylene packaging. The result is less use of oil and a better outcome for the environment. It's a strong proposition.
It's a classic microcap story with all of the fundamentals in place for soaring growth -- a unique technology platform that's been validated by major customers worldwide, an experienced and proven management team, and powerful market drivers bolstered by increasing demand.
This company is addressing markets representing annual sales in the tens of billions of dollars, it has proven technology and products that are being rapidly adopted by large corporate customers, it has manufacturing capacity to scale several times current production, and its products are already on parity with polypropylene now that oil prices are north of $100.
In 2010, sales revenue for this company was $6.3 million, a 133% increase versus 2009, and projected revenue for the 2011 full year is between $24 million and $32 million -- a whopping 300% to 400% increase over 2010!
With all this going for it, this company is still valued well below $100 million. That's the kind of microcap opportunity I absolutely love!
Q: Investorideas.com
What percentage of your portfolio is in the cleantech space currently and are you looking to add more companies in the space over this year?
A: Josh Levine, MicroCap Investor
About one-third of the MicroCap Investor portfolio is devoted to cleantech companies, and I've got several top prospects in my sights. It's tough to predict, but I suspect I'll be adding at least a couple of more cleantech plays to our portfolio this year.
It's really a matter of quality, not quantity, and I am extremely bullish on the current group we have today. Still, cleantech is a ripe sector and it will yield tremendous opportunities year after year for a very long time. Every growth-oriented investor should make sure a healthy portion of his or her equities portfolio is allocated to cleantech.
Read the full Q&A Interview:
http://www.investorideas.com/news/2011/main/03031.asp
Josh Levine's MicroCap Investorhttp://www.levinesmicrocapinvestor.com
Levine's MicroCap Investor delves deep into the world of small stocks to identify big winners, targeting innovative companies on the path of the new and revolutionary.
The strategy for MicroCap Investor is simple: to focus on small, innovative companies representing the best pure plays in the fast-growing waves of change in biotechnology, cleantech, and emerging IT.
About Josh Levine
Levine has 25 years of senior-level experience in analyzing technology trends and investing in top-performing micro- and small-cap stocks. He excels at assessing management teams and evaluating new innovations and their impact on corporate valuations.
More on Levine's bio: http://www.levinesmicrocapinvestor.com/aboutus/
To learn more about the investment opportunities in the MicroCap Investor portfolio, and how to subscribe:
http://www.levinesmicrocapinvestor.com/subscriptions/order/
InvestorIdeas.com has partnered with Josh Levine and MicroCap Investor as part of its mission to provide investors with research tools to explore the world of small stocks. The InvestorIdeas.com team operates this web site and manages the administration and marketing for MicroCap Investor.
InvestorIdeas.com is a leading investment and industry research portal, with resources covering high-growth sectors including technology, biotech and cleantech.
Research cleantech stocks with the Investorideas.com renewable energy, water and environment stock directories. Learn more:
http://www.investorideas.com/membership/
Levine's Microcap Investor
Disclaimer:http://www.levinesmicrocapinvestor.com/disclosure/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising
Investorideas.com - a leader in cleantech investor research
Contact us
Dvanzant@investorideas.com
800 665 0411

Point Roberts, WA - March 29, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, reports on advances in Cancer Immunotherapy. Bristol-Myers Squibb Company (NYSE:BMY) announced Friday that the U.S. Food and Drug Administration (FDA) approved YERVOY� (ipilimumab) 3 mg/kg for the treatment of patients with unresectable (inoperable) or metastatic melanoma.

Bristol-Myers Squibb Company (NYSE:BMY) hit a 52 week high on Friday.
"The approval of YERVOY illustrates the power of harnessing the patient's own immune system to combat cancer," stated Jim Joyce, CEO of Aethlon Medical. "With the recent approval of PROVENGE from Dendreon, the cancer immunotherapy era seems to be well underway. In this regard, we believe that the elimination of particles released by cancers to suppress the immune response would further unlock the benefit of Yervoy, Provenge, and other immunotherapy candidates in the clinical pipeline."
Aethlon Medical (OTCBB: AEMD) recently discovered that it's Hemopurifier®, a dialysis-like device with broad-spectrum capabilities to capture infectious viral pathogens from circulation, also captures tumor-secreted exosomes that cause programmed cell death of the immune cells required to fight cancer.
Dendreon Corporation (NasdaqGS: DNDN ) was the first to receive FDA approval for its
PROVENGE® (sipuleucel-T) immune cell treatment of cancer. According to the company, it is the first autologous cellular immunotherapy AUTOLOGOUS CELLULAR IMMUNOTHERAPYPROVENGE is classified by the FDA as an autologous cellular immunotherapy. It is designed to be an active cellular immunotherapy. Closeto receive FDA approval for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. PROVENGE is designed to induce an immune response against prostate cancer.
RecentBristol-Myers Squibb Company (NYSE:BMY) News:
FDA Approves YERVOY™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer
First and Only Approved Therapy for Unresectable or Metastatic Melanoma to Demonstrate a Significant Improvement in Overall Survival
First FDA-Approved Therapy for Unresectable or Metastatic Melanoma in More than a Decade
First Approved Cancer Immunotherapy for Melanoma to Target CTLA-4 and First FDA-Approved Compound in the Company's Robust Immuno-Oncology Pipeline Risk Evaluation and Mitigation Strategy Developed with FDA to Support the Safe and Appropriate Use of YERVOY and Help Inform Patients and Providers About Important Safety Risks
PRINCETON, N.J. - (Investorideas.com Newswire) - Bristol-Myers Squibb Company (NYSE:BMY) announced that the U.S. Food and Drug Administration (FDA) approved YERVOY™ (ipilimumab) 3 mg/kg for the treatment of patients with unresectable (inoperable) or metastatic melanoma. YERVOY is the first and only therapy for unresectable or metastatic melanoma to demonstrate a significant improvement in overall survival based on results from a pivotal randomized, double-blind Phase 3 study. Median overall survival was 10 months (95% CI: 8.0-13.8) for YERVOY, 6 months (95% CI: 5.5-8.7) for gp100 and 10 months (95% CI: 8.5-11.5) for YERVOY + gp100, with p-values of 0.0026 (not adjusted for multiple comparisons) for YERVOY and 0.0004 for YERVOY + gp100 vs. gp100, respectively. As published in the New England Journal of Medicine, the Kaplan-Meier estimated survival rate at 1 year was 46% (95% CI: 37.0, 54.1) in the YERVOY arm vs. 25% (95% CI: 18.1, 32.9) in the gp100 arm. The estimated survival rate at 2 years was 24% (95% CI: 16.0, 31.5) in the YERVOY arm vs. 14%2 (95% CI: 8.0, 20.0) in the gp100 arm. YERVOY, which is a recombinant, human monoclonal antibody, is the first FDA-approved cancer immunotherapy that blocks the cytotoxic T- lymphocyte antigen-4 (CTLA-4).
Full News: http://www.investorideas.com/news/2011/main/03281.asp
Biotech/Pharma Sector Snapshot Trading March 28th
Aethlon Medical (OTCBB: AEMD) traded in a range: $0.13 - 0.1380
Bristol-Myers Squibb Company (NYSE: BMY ) Day's Range: $26.94 - $27.38 on over 18 Million shares
Dendreon Corporation (NasdaqGS: DNDN ) closed at $33.96, up $1.01 (3.07%) with further gains in after hours trading.
Company Snapshot
About Aethlon Medical (OTCBB: AEMD)
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings .
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011      
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Oil and Gas Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces NOS227 Well Completion Underway at North Oklahoma Project


SCOTTSDALE, AZ � March 29, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is pleased to announce that the NOS227 well completion is underway at the North Oklahoma Project. The work over rig has arrived on site and commenced activities in order to finish the well and put it into commercial production.

When completed, NOS227 will become the 3rd production well at the North Oklahoma Project in Payne County, Oklahoma. The well was drilled to 3,820 feet and the completion plan has begun to test and complete for immediate and future production of the three objective formations which include 85 feet in the Mississippi, 45 feet in the Woodford Shale, and 4 feet in the Simpson. It is anticipated that co-mingled Mississippi/Woodford production could result in 100 to 150 BPD potential.
Electronic log data of the oil bearing formations underlying NOS227 indicates that the lower Simpson formation provides oil shows offering excellent permeability and porosity and will be perforated and tested first. Following that, the Company plans to move up hole and acidize the Woodford which appears to have better porosity characteristics than what was encountered at the previously drilled No. 1 well where acidizing resulted in swab rates of 80 barrels per day. As part of the completion of this formation, a light fracture stimulation ("Frac") of the Woodford is anticipated. Lastly, the 85 foot thick Mississippi will be acidized and fracked.
All three zones contain oil shows having the requisite permeability and porosity to produce oil in commercial quantities and the well has been cased to depth. Based on an engineering analysis of the well and logs, the Company believes the possibility of a Mississippi-Woodford well with comingled production from both formations is estimated to have a 100-150 BPD potential. Additional production may occur from the Simpson however, as the zone is limited, it may prove prudent to hold the added resource behind pipe with the reserve categorized as Proved Undeveloped.
American Petro-Hunter has a 50% interest in the well. Production from NOS227 will be sold alongside output from the No. 1 and NOJ26 wells to Sunoco, the regional purchaser. West Texas Intermediate Crude today has recently been priced at $104 per barrel.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)

Clean Energy Stocks Alert; Clean Energy Fuels (Nasdaq:CLNE), (OTCBB:EVCA), (NasdaqGS:FSYS), (NasdaqGS:WPRT)

March 28, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leader in cleantech investor research, reports on recent clean energy vehicle news for investors following the sector. With the recent nuclear disaster in Japan, investors and industry are taking a more serious look at natural gas as a clean energy alternative. Stocks like Clean Energy Fuels Corp. (Nasdaq:CLNE) and Westport Innovations Inc (NasdaqGS: WPRT) have benefited from the renewed interest in clean energy fuel.

Oil is currently trading at $104.09 -1.31 -1.24%.
Alternative Energy Vehicle Sector Snapshot

• Clean Energy Fuels Corp. (Nasdaq:CLNE) $ 14.55, up 0.50 (3.56%) 2:17PM EDT
• EVCARCO (OTCBB: EVCA) trading a $0.018- 0.02, with a recent high of $0.10
• Fuel Systems Solutions, Inc. (NasdaqGS: FSYS ) trading at $25.63 0.38 (1.51%) 1:56PM EDT
• Westport Innovations Inc (NasdaqGS: WPRT ) (WPT.TO) trading at $19.08, up 0.36 (1.92%) 2:11PM EDT

Market Snapshot;

• Dow 12,239.58 +18.99 +0.16%
• Nasdaq 2,744.24 +1.18 +0.04%
• S&P 500 1,315.16 +1.36 +0.10%
• 10 Yr Bond (%) 3.4440% 0.0000
• Oil 104.09 -1.31 -1.24%

Company Snapshots
Clean Energy Fuels (Nasdaq:CLNE)
Clean Energy fuels more than 19,900 vehicles at 211 strategic locations across the United States and Canada with a broad customer base in the refuse, transit, trucking, shuttle, taxi, airport and municipal fleet markets. It owns (70%) and operates a landfill gas facility in Dallas that produces renewable methane gas, or biomethane, for delivery in the nation's gas pipeline network. It owns and operates LNG production plants in Willis, Texas and Boron, Calif. with combined capacity of 260,000 LNG gallons per day and that are designed to expand to 340,000 LNG gallons per day as demand increases. NorthStar, a wholly owned subsidiary, is the recognized leader in LNG/LCNG (liquefied to compressed natural gas) fueling system technologies and station construction and operations. BAF Technologies, Inc., a wholly owned subsidiary, is a leading provider of natural gas vehicle systems and conversions for taxis, vans, pick-up trucks and shuttle buses. IMW Industries, Ltd., a wholly owned subsidiary based in Canada, is a leading supplier of compressed natural gas equipment for vehicle fueling and industrial applications with more than 1,000 installations in 24 countries.
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles
Recent News
Natural Gas News; EVCARCO (OTCBB: EVCA) to Sell Class 3-5 Commercial Compressed Natural Gas Powered Trucks at Its Green Auto Dealerships
Full news: http://www.investorideas.com/news/2011/energy/02151.asp
Westport Innovations Inc (NasdaqGS: WPRT ) is a global leader in alternative fuel, low-emissions technologies that allow engines to operate on clean-burning fuels such as compressed natural gas (CNG), liquefied natural gas (LNG), hydrogen, and biofuels such as landfill gas. Our unique technologies reduce nitrogen oxides (NOx), particulate matter (PM), and greenhouse gas emissions (GHG) while preserving the power, torque, and fuel efficiency of diesel engines. The Company focuses on three distinct categories or target markets - light-, medium-, and heavy-duty - through Westport business units or joint ventures. Juniper Engines is focused on 2.4L engines for industrial applications such as forklifts, oilfield service engines and light-duty automotive. Cummins Westport (CWI), a joint venture with Cummins, sells the world's broadest range of low-emissions alternative fuel engines for commercial urban fleets such as buses, refuse trucks and vocational vehicles ranging from 5.9L to 8.9L. Westport Heavy Duty (Westport HD), our proprietary development platform, is engaged in the engineering, design and marketing of natural gas-enabling technology for the heavy-duty diesel engine and truck market
Research green car stocks, lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.

Wind Stocks Trading Alert; Clean Wind Energy Tower, Inc. (OTCBB: CWET), PowerShares Global Wind Energy (NasdaqGM: PWND), China Ming Yang Wind (NYSE: MY)

Point Roberts, WA - March 28, 2011 - Investorideas.com, a leader in cleantech stock research, reports on recent wind stocks news and developments for wind stocks. New wind stocks were recently added to the NASDAQ OMX Clean Edge Global Wind Energy Index. Wind stocks and solar stocks continue to be in the spotlight with investors looking for alternatives to nuclear power and oil.

Oil is trading at $104.43 -0.97 -0.92%.
Wind Stocks Snapshot; Morning Trading
Wind ETF's

• First Trust ISE Global Wind Energy (NYSEArca: FAN ) trading at 11.80, up 0.28 (2.43%) 1:11PM EDT
• PowerShares Global Wind Energy (NasdaqGM: PWND ) trading up at 11.41, up 0.25 (2.24%)
• Wind Stocks
• Broadwind Energy, Inc. (NasdaqGS: BWEN ) trading at $ 1.36, down 0.01 (0.73%)
• China Ming Yang Wind Power Group (NYSE: MY ) trading at $10.27, up 0.17 (1.68%) 12:53PM EDT
• Clean Wind Energy Tower, Inc. (OTCBB: CWET) trading at $0.24
• Juhl Wind Inc. (OTCBB: JUHL) trading at $ 1.10. down 0.05 (4.35%)
• Plutonic Power Corporation (PCC.TO) trading at $ 2.73, down 0.01 (0.36%)

Market Snapshot

• Dow 12,250.75 +30.16 +0.25%
• Nasdaq 2,746.94 +3.88 +0.14%
• S&P 500 1,316.85 +3.05 +0.23%
• 10 Yr Bond (%) 3.4500% +0.0060
• Oil 104.43 -0.97 -0.92%
• Gold 1,426.10 0.00 0.00%

Recent Wind News:
Clean Wind Energy Tower, Inc. (OTCBB: CWET) Files Unique Hydraulic System Patent
Maximizing the Capture and Use of Available Wind Tunnel Energy
ANNAPOLIS, MD - March 7, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET) announced that the Company had filed with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
Full news: http://www.investorideas.com/CO/CWE/news/2011/03071.asp
Semi-Annual Changes to the NASDAQ OMX Clean Edge Global Wind Energy Index
NEW YORK , March 21, 2011 -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) and Clean Edge, Inc. announced today the results of the semi-annual evaluation of the NASDAQ OMX(R) Clean Edge(R)
Global Wind Energy Index (Nasdaq:QWND), which will become effective with the market open today.
The following four securities will be added to the Index: ABB Ltd (ABBN VX), Broadwind Energy, Inc. (BWEN UQ), Enel Green Power S.p.A. (EGPW EB), and China Ming Yang Wind Power Group Limited (MY UN).
The Index is designed to act as a transparent and liquid benchmark for the global wind energy sector. The Index includes companies that are primarily manufacturers, developers, distributors, installers, and users of energy derived from wind sources. The securities must also meet other eligibility criteria which include minimum requirements for market capitalization and average daily dollar trading volume. The NASDAQ OMX(R) Clean Edge(R) Global Wind Energy Index is evaluated semi-annually in March and September. For more information about the NASDAQ OMX(R) Clean Edge(R) Global Wind Energy Index, including detailed eligibility criteria, visit https://indexes.nasdaqomx.com/.
The NASDAQ OMX Clean Edge Global Wind Energy Index is the basis for the PowerShares Global Wind Energy Portfolio (Nasdaq:PWND - News), which seeks investment results that correspond generally to the price and yield of the NASDAQ OMX Clean Edge Global Wind Energy Index before fees and expenses.
As a result of the evaluation, the following four securities will be removed from the Index: Japan Wind Development Co., Ltd. (2766 JT), ABB Ltd -- ADR (ABB UN), Endesa SA (ELE SM), and Enel SpA (ENEL IM).
About NASDAQ OMX Global Index Group
NASDAQ OMX Global Index Group is engaged in the design, development, calculation, licensing, and marketing of NASDAQ OMX Indexes. NASDAQ OMX Global Index Group specializes in the development of indexes focusing on NASDAQ OMX's brand themes of innovation, technology, growth, and globalization. NASDAQ OMX Global Index Group also provides custom index services and design solutions as a third-party provider to selected financial organizations. For more information about NASDAQ OMX indexes, visit www.nasdaq.com/indexes.
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Wind Company Snapshot
Clean Wind Energy Tower, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., was established to commercialize a number of proven and validated technologies and construction systems into a single large downdraft tower structure that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, Clean Wind Energy, Inc. has assembled a world class team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market.
Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. The Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity .
www.cleanwindenergytower.com
Visit the showcase page at Investorideas.com : http://www.investorideas.com/CO/CWE/
Broadwind Energy (NASDAQ:BWEN ) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and heavy industries, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy's talented team of more than 800 employees is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com.
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on (OTCBB: CWET)
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares ) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com